Serum Vitamin D and Gingival Crevicular Fluid Levels of Osteocalcin and N-Terminal Telopeptide

Ondokuz Mayıs University

Status: Completed

Conditions: D Vitamin Deficiency; Osteocalcin; Gingival Crevicular Fluid

Study type: Observational

Funder types: Other

Identifiers

NCT06871631

OMU KAEK protokol no: 2017/60

Details and patient eligibility

About

This study examines the relationship between serum vitamin D levels and bone metabolism markers-osteocalcin and N-terminal telopeptide (NTx)-in gingival crevicular fluid (GCF) of periodontally healthy and periodontitis patients. A total of 120 male participants (60 healthy, 60 with periodontitis) aged 25-40 were included and categorized based on their serum vitamin D levels.

Full description

Recent evidence suggests that vitamin D, a key regulator of bone metabolism, may play a role in periodontal health by influencing bone turnover markers such as osteocalcin and N-terminal telopeptide (NTx). This study aims to investigate the effects of serum vitamin D levels on these bone metabolism markers in gingival crevicular fluid (GCF) of periodontally healthy and periodontitis patients.

A total of 120 male participants aged 25-40 years were enrolled, comprising 60 periodontally healthy individuals and 60 patients diagnosed with periodontitis. Participants were further categorized into subgroups based on their serum vitamin D levels (0-10 ng/ml, 11-20 ng/ml, and 21-30 ng/ml). GCF samples were collected from maxillary premolar and molar sites and analyzed using enzyme-linked immunosorbent assay (ELISA) to measure osteocalcin and NTx concentrations.

Enrollment: 120 patients

Sex: Male

Ages: 25 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• One hundred and twenty male patients, consisting of 60 periodontally healthy patients and 60 patients with periodontitis, aged between 25 and 40 years, non-smoking, who had not received periodontal treatment in the last 6 months, with no systemic diseases, and whose Vitamin D levels had been determined, were included in the study.

Exclusion criteria

• Female individuals
• Smokers
• Individuals with systemic diseases (Diabetes Mellitus, Hyperthyroidism, -Malabsorption, Liver and Renal Failure, or those receiving osteoporosis treatment)
• Individuals who have undergone periodontal treatment within the last 6 months
• Individuals on regular medication
• Individuals who did not provide informed consent
• Individuals with poor cooperation

Trial design

120 participants in 6 patient groups

Patients with periodontitis and 25(OH)D levels of 0-10 ng/ml

Description:

Patients diagnosed with periodontitis who have serum 25-hydroxyvitamin D \[25(OH)D\] levels ranging from 0 to 10 ng/ml.

Patients with periodontitis and 25(OH)D levels of 11-20 ng/ml

Description:

Patients diagnosed with periodontitis who have serum 25-hydroxyvitamin D \[25(OH)D\] levels ranging from 11 to 20 ng/ml.

Patients with periodontitis and 25(OH)D levels of 21-30 ng/ml

Description:

Patients diagnosed with periodontitis who have serum 25-hydroxyvitamin D \[25(OH)D\] levels ranging from 21 to 30 ng/ml.

Periodontally healthy patients and 25(OH)D levels of 0-10 ng/ml

Description:

Periodontally healthy patients with serum 25-hydroxyvitamin D \[25(OH)D\] levels between 0 and 10 ng/ml.

Periodontally healthy patients and 25(OH)D levels of 11-20 ng/ml

Description:

Periodontally healthy patients with serum 25-hydroxyvitamin D \[25(OH)D\] levels between 11 and 20 ng/ml.

Periodontally healthy patients and 25(OH)D levels of 21-30 ng/ml

Description:

Periodontally healthy patients with serum 25-hydroxyvitamin D \[25(OH)D\] levels between 21 and 30 ng/ml.